We use necessary cookies to make our website work. We also use optional statistical, functional and marketing cookies that you can choose to decline in your preference setting. For more information about the use of cookies or our use of data, see our Cookies notice or Privacy notice

Cookies settings I agree I disagree

Cookies information

Our site uses tools, such as cookies, to analyze and improve your experience. You can unsubscribe below:

Statistic

We use tools such as Google Analytics to track web traffic and check the effectiveness of our site.

Necessary

Cookies required for essential services and features such as login forms, shopping cart integration and access control. Without them, our website cannot function properly and we cannot provide any services. Deactivation is not available.

These settings will be kept for 24h

Products

BIOX-101

Unique mechanism of action of BIOX-101

BIOX-101 (scientific name: Ir-CPI) is a recombinant version of a small protein found in the saliva of the tick (Ixodes ricinus). Ticks have developed sophisticated mechanisms enabling them to feed on the blood of their hosts. Tick saliva contains various bioactive substances which overcomes the host’s immune defenses so as to avoid detection, and prevents blood clotting.

BIOX-101 displays a powerful dual mode of action that tackles thromboinflammation at its root. Firstly, it inhibits neutrophils - a type of white blood cells - and the formation of the Neutrophil Extracellular Traps (NETs). Neutrophils are the first responders of the immune system, but they can also cause damaging secondary effects after a stroke, such as swelling of the brain, tissue damage and neuronal death.

Secondly, BIOX-101 has an antithrombotic effect through its interaction with upstream blood coagulation factors (FXIa/FXIIa) of the intrinsic pathway. Critically, it does so without increasing the risk of bleeding.

The combination of these anti-inflammatory and antithrombotic properties makes BIOX-101 a promising candidate for a range of thrombo-inflammatory diseases, starting with hemorrhagic stroke.

BIOX-101 downregulates the thromboinflammatory cascade

BIOX-101 downregulates the thromboinflammatory cascade